Lupin informs about press release

19 Feb 2021 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it has enclosed a Press Release on 19th February 2021 as regards receipt of USFDA approval for the Company's Droxidopa Capsules, 100 mg, 200 mg and 300 mg, to market a generic equivalent of Northera Capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2331.75 34.55 (1.50%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×